{"schema_version":"1","generated_at":"2026-10-28T06:04:34.432Z","data_as_of":"2026-10-26","url":"https://www.findmykol.com/kol/colette-shen","json_url":"https://www.findmykol.com/kol/colette-shen/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"colette-shen","name":"Colette Shen","credential":"MD","title":"Assistant Professor, University of North Carolina","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Head & Neck","therapeutic_areas":["Head & Neck","Neuro-Oncology"],"institution":"University of North Carolina at Chapel Hill","institution_url":"https://www.findmykol.com/institution/university-of-north-carolina-at-chapel-hill","city":"Chapel Hill","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1679830699","orcid":"0000-0002-3855-7360","openalex":"A5040202861"},"summary":"Colette Shen is Assistant Professor, University of North Carolina at University of North Carolina at Chapel Hill. OpenAlex indexes 243 publications with 3,375 citations (h-index 31); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.","overview":{"text":"Colette Shen, MD, is Assistant Professor, University of North Carolina at University of North Carolina at Chapel Hill. The public record shows 243 publications with 3,375 citations (h-index 31), centered on Head and Neck Cancer Studies, Brain Metastases and Treatment, Glioma Diagnosis and Treatment. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 5 companies.","bullets":["Most recent indexed publication: 2026 · Neuro-oncology","Top research focus: Head and Neck Cancer Studies","7 registered trials on ClinicalTrials.gov","Open Payments reporting from 5 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":3,"topics":1,"strength":10},{"label":"Oropharyngeal Neoplasms","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Carcinoma, Squamous Cell","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Pharyngeal Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Xerostomia","therapeutic_area":"Head & Neck","trials":2,"topics":0,"strength":6},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Head and Neck Cancer Studies","Brain Metastases and Treatment","Glioma Diagnosis and Treatment","Cancer Immunotherapy and Biomarkers","Advanced Radiotherapy Techniques"],"works_with":{"total":9,"shown":3,"withheld":6,"rows":[{"name":"UNC Lineberger Comprehensive Cancer Center","trials":4,"payments":0,"mentions":4},{"name":"Janssen Scientific Affairs, LLC","trials":0,"payments":3,"mentions":3},{"name":"Novocure Inc.","trials":0,"payments":2,"mentions":2}]}},"scholarship":{"works_count":243,"cited_by_count":3375,"h_index":31,"i10_index":54,"pubmed_count":7,"latest_activity_year":2026,"source":"works"},"trials":{"count":7,"shown":3,"withheld":4,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06276946","title":"Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia","phase":"NA","status":"WITHDRAWN","role":"Investigator","sponsor":"UNC Lineberger Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06276946","trial_url":"https://www.findmykol.com/trial/NCT06276946"},{"nct":"NCT05451004","title":"SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"Canadian Cancer Trials Group","source_url":"https://clinicaltrials.gov/study/NCT05451004","trial_url":"https://www.findmykol.com/trial/NCT05451004"},{"nct":"NCT04711824","title":"Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Investigator","sponsor":"Colette Shen","source_url":"https://clinicaltrials.gov/study/NCT04711824","trial_url":"https://www.findmykol.com/trial/NCT04711824"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2023,"last":2025},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Janssen Scientific Affairs, LLC","program_year":2025,"amount_usd":4605,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679830699"},{"payer":"Janssen Pharmaceuticals, Inc","program_year":2025,"amount_usd":630,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679830699"},{"payer":"Novocure Inc.","program_year":2025,"amount_usd":139.99,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679830699"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1679830699","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Sensory organs","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":17}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":0,"rows_total":3,"shown":3,"withheld":0,"rows":[{"project":"F30HL095332","title":"Cooperative regulation of angiogenesis by adhesive and soluble cues","fiscal_year":2012,"amount_usd":18933,"organization":"UNIVERSITY OF PENNSYLVANIA","source_url":"https://reporter.nih.gov/quickSearch/F30HL095332"},{"project":"F30HL095332","title":"Cooperative regulation of angiogenesis by adhesive and soluble cues","fiscal_year":2010,"amount_usd":27261,"organization":"UNIVERSITY OF PENNSYLVANIA","source_url":"https://reporter.nih.gov/quickSearch/F30HL095332"},{"project":"F30HL095332","title":"Cooperative regulation of angiogenesis by adhesive and soluble cues","fiscal_year":2009,"amount_usd":27057,"organization":"UNIVERSITY OF PENNSYLVANIA","source_url":"https://reporter.nih.gov/quickSearch/F30HL095332"}],"source":"grants"},"congress":{"count":66,"years":{"first":2014,"last":2026},"societies":["AACR","ASCO","ASTRO","ESMO"],"shown":3,"withheld":63,"rows":[{"title":"Reirradiation with NBTXR3/SBRT in combination with nivolumab or pembrolizumab for the treatment of patients with recurrent or metastatic head & neck squamous cell carcinoma (HNSCC) in the phase I trial study 1100.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.6034","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.6034","status":"verified"},{"title":"Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco-26-01894","source_url":"https://doi.org/10.1200/jco-26-01894","status":"verified"},{"title":"An 8-year single institution review of demographic trends and treatment patterns among patients with anaplastic thyroid carcinoma.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e18139","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e18139","status":"verified"}],"source":"congress"},"publications":{"total":7,"shown":5,"withheld":2,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort.","year":2026,"journal":"Neuro-oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42747321/","status":"verified"},{"title":"Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial.","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42804720/","status":"verified"},{"title":"Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis.","year":2026,"journal":"Journal of neuro-oncology","types":["Journal Article","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41663549/","status":"verified"},{"title":"Commentary: Long-Term Outcomes After CyberKnife Radiosurgery for Nonfunctioning Pituitary Adenomas.","year":2025,"journal":"Neurosurgery","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40084896/","status":"verified"},{"title":"Radiation therapy for infants with cancer.","year":2021,"journal":"Pediatric blood & cancer","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/33818894/","status":"verified"}],"most_cited":{"total":243,"shown":5,"withheld":238,"rows":[{"title":"Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer","year":2020,"cited_by_count":418,"type":"article","source_url":"https://doi.org/10.1200/jco.19.02444"},{"title":"The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function","year":2004,"cited_by_count":310,"type":"article","source_url":"https://doi.org/10.1016/j.biomaterials.2004.08.012"},{"title":"Bioactive hydrogels made from step-growth derived PEG–peptide macromers","year":2010,"cited_by_count":215,"type":"article","source_url":"https://doi.org/10.1016/j.biomaterials.2010.01.058"},{"title":"Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma","year":2019,"cited_by_count":212,"type":"article","source_url":"https://doi.org/10.1200/jco.19.01007"},{"title":"Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics","year":2018,"cited_by_count":155,"type":"article","source_url":"https://doi.org/10.1016/j.ijrobp.2018.05.041"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Bhishamjit S. Chera","coauthored_works":72},{"name":"Trevor Hackman","coauthored_works":59,"profile_url":"https://www.findmykol.com/kol/trevor-hackman"},{"name":"Jared M. Weiss","coauthored_works":53}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/colette-shen-md","status":"verified"}]},"mentions":{"total":2,"shown":2,"rows":[{"url":"https://pdsoros.org/?p=1249","platform":"other","status":"verified"},{"url":"https://unclineberger.org/directory/colette-shen/","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"BA, Engineering Sciences, Harvard University (2004)","source_url":"https://pdsoros.org/?p=1249","status":"provisional","collected_at":"2026-10-26"},{"value":"MD, PhD (Bioengineering), University of Pennsylvania","source_url":"https://pdsoros.org/?p=1249","status":"provisional","collected_at":"2026-10-26"},{"value":"MD","source_url":"https://unclineberger.org/unccn/participant-survey-2/","status":"provisional","collected_at":"2026-10-26"}]},"awards":{"total":2,"shown":2,"rows":[{"value":"Paul & Daisy Soros Fellowship (2006)","source_url":"https://pdsoros.org/?p=1249","status":"verified","collected_at":"2026-10-26"},{"value":"Research honored by the National Inventors Hall of Fame","source_url":"https://pdsoros.org/?p=1249","status":"provisional","collected_at":"2026-10-26"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Director, UNC Cyberknife Center","source_url":"https://www.med.unc.edu/neurosurgery/services/brain-tumors/radiation-oncology/","status":"provisional","collected_at":"2026-10-26"}]}},"similar":[{"name":"Lisa Carey","slug":"lisa-carey","institution":"University of North Carolina at Chapel Hill","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/lisa-carey","json_url":"https://www.findmykol.com/kol/lisa-carey/profile.json"},{"name":"Diana Perkins","slug":"diana-perkins","institution":"University of North Carolina at Chapel Hill","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/diana-perkins","json_url":"https://www.findmykol.com/kol/diana-perkins/profile.json"},{"name":"Douglas Drossman","slug":"douglas-drossman","institution":"University of North Carolina at Chapel Hill","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/douglas-drossman","json_url":"https://www.findmykol.com/kol/douglas-drossman/profile.json"},{"name":"Michael Knowles","slug":"michael-knowles","institution":"University of North Carolina at Chapel Hill","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/michael-knowles","json_url":"https://www.findmykol.com/kol/michael-knowles/profile.json"},{"name":"Neal Futran","slug":"neal-futran","institution":"University of Washington (UW Medicine)","specialty":"Plastic Surgery within the Head & Neck","url":"https://www.findmykol.com/kol/neal-futran","json_url":"https://www.findmykol.com/kol/neal-futran/profile.json"},{"name":"Everett Vokes","slug":"everett-vokes","institution":"University of Chicago","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/everett-vokes","json_url":"https://www.findmykol.com/kol/everett-vokes/profile.json"},{"name":"Maura Gillison","slug":"maura-gillison","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/maura-gillison","json_url":"https://www.findmykol.com/kol/maura-gillison/profile.json"},{"name":"Antonio Jimeno","slug":"antonio-jimeno","institution":"University of Colorado Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/antonio-jimeno","json_url":"https://www.findmykol.com/kol/antonio-jimeno/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":4,"payments":3,"congress":63,"publications":2,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-26"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2023 to 2025","collected_at":"2026-10-26"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-26"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}